News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Smith Mark Alan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2022 |
4
| Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 2,655 shares
@ $1.6575, valued at
$4.4k
|
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2020 |
4
| Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $0.398, valued at
$59.7k
|
|
| 10/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2019 |
4
| Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1, valued at
$150k
|
|
| 08/31/2018 |
4
| Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Disposed/sold 180,000 options to buy
@ $3.49, valued at
$628.2k
Granted 180,000 options to buy
@ $1.5, valued at
$270k
Disposed/sold 80,000 options to buy
@ $3.8, valued at
$304k
Granted 80,000 options to buy
@ $1.5, valued at
$120k
Disposed/sold 125,000 options to buy
@ $1.96, valued at
$245k
Granted 125,000 options to buy
@ $1.5, valued at
$187.5k
|
|
| 08/06/2018 |
4
| Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.27, valued at
$127k
|
|
| 02/05/2018 |
4
| Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $1.16, valued at
$232k
|
|
| 09/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/21/2016 |
4
| Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 180,000 options to buy
@ $3.49, valued at
$628.2k
|
|
| 06/21/2016 |
3
| Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 3 on VistaGen Therapeutics, Inc. |
|
|